acebutolol has been researched along with Syndrome in 4 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This report describes the case of a 4-year-old boy diagnosed with Smith-Magenis syndrome in whom treatment with a beta(1)-adrenergic antagonist in the morning (to suppress the diurnal melatonin secretion) and melatonin in the evening (to generate a nocturnal peak of melatonin) improved his sleep quality, evaluated by polysomnographic studies." | 7.73 | Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. ( Abad, A; Carpizo, R; González, M; Martínez, A; Mediavilla, D; Sánchez-Barceló, EJ, 2006) |
| "This report describes the case of a 4-year-old boy diagnosed with Smith-Magenis syndrome in whom treatment with a beta(1)-adrenergic antagonist in the morning (to suppress the diurnal melatonin secretion) and melatonin in the evening (to generate a nocturnal peak of melatonin) improved his sleep quality, evaluated by polysomnographic studies." | 3.73 | Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. ( Abad, A; Carpizo, R; González, M; Martínez, A; Mediavilla, D; Sánchez-Barceló, EJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Leersnyder, H | 2 |
| Bresson, JL | 1 |
| de Blois, MC | 2 |
| Souberbielle, JC | 1 |
| Mogenet, A | 1 |
| Delhotal-Landes, B | 1 |
| Salefranque, F | 1 |
| Munnich, A | 2 |
| Carpizo, R | 1 |
| Martínez, A | 1 |
| Mediavilla, D | 1 |
| González, M | 1 |
| Abad, A | 1 |
| Sánchez-Barceló, EJ | 1 |
| Vekemans, M | 1 |
| Sidi, D | 1 |
| Villain, E | 1 |
| Kindermans, C | 1 |
| Romeo, F | 1 |
| Gaspardone, A | 1 |
| Ciavolella, M | 1 |
| Gioffrè, P | 1 |
| Reale, A | 1 |
2 trials available for acebutolol and Syndrome
| Article | Year |
|---|---|
Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.
Topics: Abnormalities, Multiple; Acebutolol; Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic | 2003 |
Verapamil versus acebutolol for syndrome X.
Topics: Acebutolol; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Mi | 1988 |
2 other studies available for acebutolol and Syndrome
| Article | Year |
|---|---|
Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antioxidants; Child, Preschool; Chromosome Deletion; Chromo | 2006 |
beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Behavior; Child; Child, Preschool; Chromosomes, | 2001 |